Strata Skin Sciences (NSDQ:SSKN) announced that it won FDA 510(k) clearance for its Xtrac Momentum excimer laser system for treating a number of skin diseases. The Xtrac laser is designed to deliver a highly targeted therapeutic beam of UVB light in the treatment of psoriasis, vitiligo, eczema, atopic dermatitis and leukoderma. It is made in three […]
Strata Skin Sciences inks Korea distribution deal
Strata Skin Sciences (NSDQ:SSKN) today announced a new Korean direct distribution deal with Kosmo Meditech for direct capital sales and direct recurring revenue sales in Korea. Kosmo Meditech has worked with Strata Skin Sciences for more than 13 years. The deal with help strengthen Strata’s Xtrac excimer laser value proposition in Korea and expand its installed […]
Strata Skin Sciences files motion for contempt against Ra Medical
Strata Skin Sciences (NSDQ:SSKN) has filed a motion for contempt against Ra Medical (NYSE:RMED) in an ongoing legal battle in which Ra Medical claims Strata and its board chair Uri Geiger made misleading and disparaging statements to financial partners in the time frame surrounding Ra Medical’s initial public offering. In their complaint, Horsham Township, Penn.-based Strata Skin Sciences […]
Ra Medical files trade libel, settlement breach suit against Strata Skin Sciences
Ra Medical (NYSE:RMED) said today they filed a suit against Strata Skin Sciences (NSDQ:SSKN) and its board chair Uri Geiger claiming that the parties “undertook a campaign of false, misleading and disparaging statements” to the company’s financial partners before, during and after its initial public offering. The Carlsbad, Calif.-based company said that it filed the complaint in […]
Strata Skin Sciences adds license for excimer laser vitiligo treatment
Strata Skin Sciences (NSDQ:SSKN) said it has reached an agreement with an “internationally acclaimed health institution” giving Strata an exclusive license to treat vitiligo using its Xtrac excimer laser. In a novel treatment for vitiligo, the excimer laser incrementally increases the light emitted in the UVB range to restore pigmentation to skin areas affected with […]
Strat Skin Sciences wins FDA nod for Multi-Micro Dose excimer laser tip
Strata Skin Sciences (NSDQ:SSKN) said yesterday it won FDA 510(k) clearance for the Multi-Micro Dose tip designed for use with its Xtrac 308nm excimer laser. The newly cleared tip is indicated for use in conjunction with the Horsham, Penn.-based company’s Xtrac laser system to filter narrow band UVB light at delivery, intended to individualize non-blistering doses […]
Strata Skin Sciences raises $17m, refreshes exec roster
Strata Skin Sciences (NSDQ:SSKN) said today it raised $17 million in a new round of financing and announced a number of changes to its executive roster, including an incoming CEO, new board chair and new chief financial officer. The Horsham, Penn.-based company said that the $17 million round of financing was led by Accelmed Growth Partners […]
OptiScan taps ex-Hansen Medical chief Vance for CEO | Personnel Moves, May 23, 2018
OptiScan taps ex-Hansen Medical chief Vance for CEO OptiScan Biomedical tapped former Myoscience and Hansen Medical chief Cary Vance to be its new CEO, replacing interim head William Mince. “I am excited to join OptiScan at this pivotal point in the company’s growth. I believe that the cutting-edge OptiScanner diagnostic system provides a unique platform […]
Strata Skin Sciences raises $17m, taps Rafaeli as CEO
Strata Skin Sciences (NSDQ:SSKN) said today it raised $17 million in a new round of financing, and that investor Dr. Dolev Rafaeli is slated to take over as interim CEO, with former chief exec Frank McCaney taking the role of interim CFO. In the sale, the Horsham, Penn.-based company said it floated 15.7 million shares of […]
Strata Skin Sciences to explore ‘strategic alternatives’
Strata Skin Sciences (NSDQ:SSKN) said today that its board of directors has begun a process to explore and review “strategic alternatives” focused on improving shareholder value, which could include a sale of the company or other transactions. The Horsham, Penn.-based company said that as part of its exploration of strategic alternatives, it is in the process […]
FDA details possible regulatory paths for Strata Sciences Optimal Dosing Tech
Strata Skin Sciences (NSDQ:SSKN) said this week it received a response letter from the FDA concerning possible 510(k) clearance paths for its Optimal Dosing Technology initially designed for treating psoriasis, vitiligo and other skin conditions. The Horsham, Penn.-based said the federal watchdog proposed 2 alternative paths, the 1st of which would require a clinical trial to […]
